ADL-T2 20mg
SKU: ADL-TZP-20
Strength
20mg
Purity
99.636% Purity
ADL-T2 20mg (Tirzepatide) is a synthetic peptide with dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist activity. It is offered for laboratory investigation of incretin-receptor signaling, comparative receptor pharmacology, and downstream pathways associated with glucose regulation and energy metabolism. Nominal content: 20mg per vial. Batch-specific third-party COA documentation is pending; purity, identity, and measured net content are not yet independently verified for this lot. For laboratory research use only. Not for human or veterinary use. No administration or dosing guidance is provided.
Batch #
ADL-TIR-001
Purity
99.636%
Test Date
2026-09-01
Lab
Kovera Labs
Choose vial quantity
Specifications
Nominal Content
20mg
Identity Result
Confirmed — LC-MS
Related Research Materials — ADL-T2 20mg
All compounds and content on this site are for research use only (RUO). Not for human consumption. For laboratory and research purposes only. Nothing here is medical advice.